Massive neonatal intracranial hemorrhage caused by bromadiolone

Rationale: Bromadiolone, often called a super-warfarin, is a potent rodenticide with long half-life. Skin and mucosal bleeding is the most common clinical manifestations of its intoxication. Bromadiolone intoxications in adults and children have been reported, but this phenomenon is rarely seen in fetuses. This paper presents a case of neonate with massive intracranial hemorrhage mediated by bromadiolone intoxication, highlighting that the bromadiolone is potentially lethal to the fetus. Patient Concerns: The male neonate presented with poor respiratory effort, decreased muscle tone, and pallor at birth. He developed generalized seizures on day 1 of life. His mother suffered from bleeding of oral mucosa and the subsequent lab screening for toxicants showed a bromadiolone level of 126 ng/mL. Diagnoses: Laboratory tests revealed that prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT). A computed tomography (CT) of his head revealed a severe subdural hematoma, which lead to midline shift, bilateral intraventricular hemorrhage, and subarachnoid hemorrhage. Serum from cord blood was collected and screened for toxicants. The result returned with a bromadiolone level of 94 ng/mL. Interventions: The neonate was treated with vitamin K, fresh-frozen plasma, and red blood cells. Outcomes: His parents required termination of all treatments, and the neonate unfortunately died shortly after. Lessons: Through clinical experience from this case, we believe that bromadiolone can be passed down to the fetus via placenta. Neonatal intracranial hemorrhage caused by bromadiolone is rare but potentially lethal. Pregnant women should be informed of the serious side effects of bromadiolone and this poisonous reagent should be avoided in any period during pregnancy.

[1]  M. Tran,et al.  Long-Acting Anticoagulant Rodenticide (Superwarfarin) Poisoning: A Review of Its Historical Development, Epidemiology, and Clinical Management. , 2015, Transfusion medicine reviews.

[2]  Yangyang Shi,et al.  Vitamin K treatment of brodifacoum poisoning in a pregnant woman , 2013, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[3]  Krista M. Mehlhaff,et al.  Lethal Neonatal Coagulopathy After Maternal Ingestion of a Superwarfarin , 2013, Obstetrics and gynecology.

[4]  B. Zhu,et al.  Superwarfarin rodent poisons and hemorrhagic disease. , 2012, Epidemiology.

[5]  R. Kadir,et al.  Management of pregnancy, labour and delivery in women with inherited bleeding disorders , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  N. Gunja,et al.  Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels , 2011, Clinical toxicology.

[7]  Junshik Hong,et al.  Korean Patients with Superwarfarin Intoxication and Their Outcome , 2010, Journal of Korean medical science.

[8]  A. Chan,et al.  Bromadiolone toxicokinetics: Diagnosis and treatment implications , 2008, Clinical toxicology.

[9]  M. Motas,et al.  Fatal brodifacoum poisoning in a pony. , 2007, The Canadian veterinary journal = La revue veterinaire canadienne.

[10]  T. Grobosch,et al.  Acute bromadiolone intoxication. , 2006, Journal of analytical toxicology.

[11]  Newborn,et al.  Apgar score , 2009, Radiopaedia.org.

[12]  E. A. Kelly,et al.  PREGNANCY OUTCOME AFTER MATERNAL POISONING WITH BRODIFACOUM, A LONG‐ACTING WARFARIN‐LIKE RODENTICIDE , 1997, Obstetrics and gynecology.

[13]  M. Murphy,et al.  Determination of brodifacoum and bromadiolone residues in rodent and canine liver. , 1989, American journal of veterinary research.